These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Diagnosis and treatment of postmenopausal osteoporosis after a Colles' fracture].
    Author: Morote S, Kanterewicz E, Villanueva A, García MJ, Carballido E, Yáñez A.
    Journal: Aten Primaria; 2000 Apr 15; 25(6):422-4. PubMed ID: 10857234.
    Abstract:
    OBJECTIVES: To investigate whether the presence of Colles fracture leads to diagnostic studies or treatment of osteoporosis in postmenopausal women. DESIGN: Retrospective study with follow-up of incident cases. SETTING: Hospital General de Vic and Primary Care Centre Osona. Vic. Barcelona. PARTICIPANTS AND METHODS: We studied 80 postmenopausal women with Colles' fracture during 1995-1996. The clinical records were systematically reviewed and treatment with antiosteoporotic drugs before and after Colles' fracture were compared. MEASUREMENTS AND MAIN RESULTS: Diagnostic studies were found in 3 (3.8%) patients. 6 patients (7.5%) took antiosteoporotic drugs before the fracture while 21 (26.3%, p < 0.001) did so after it. CONCLUSIONS: A recent Colles' fracture induces few osteoporosis diagnostic studies. However, it leads to a significant increase in the use of antiosteoporotic drugs. OBJETIVO: Conocer si la fractura de Colles (FC) en pacientes posmenopáusicas se utiliza para diagnosticar o tratar una posible osteoporosis subyacente. DISEÑO: Estudio retrospectivo de seguimiento de casos incidentes. EMPLAZAMIENTO: Hospital General de Vic y Centro de Asistencia Primaria Osona, Vic. Barcelona. PACIENTES Y MÉTODOS: Se incluyeron 80 mujeres posmenopáusicas con FC durante 1995-1996. Mediante revisión de las historias clínicas se valoraron las pruebas diagnósticas y se compararon los tratamientos antiosteoporóticos pre y post-FC. MEDICIONES Y RESULTADOS PRINCIPALES: En 3 casos (3,8%) se había iniciado estudio diagnóstico de osteoporosis. Seis pacientes (7,5%) recibían tratamiento antiosteoporótico antes de la FC. Después de ésta el porcentaje se había incrementado hasta un 26,3% (p < 0,001). CONCLUSIONES: La FC se utiliza en un número muy bajo de pacientes posmenopáusicas para sospechar osteoporosis, aunque su presencia aumenta el uso de fármacos antiosteoporóticos.
    [Abstract] [Full Text] [Related] [New Search]